First Trust Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

First Trust Capital Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,355,502	Closed	-$24.2M	–	181
2023 Q2	$24.2M	Hold	2,355,502	–	–	1.44%	18
2023 Q1	$23.8M	Buy	+2,355,502	New	+$23.7M	1.03%	19

First Trust Capital Management's DALS Position: Q3 2023 in Review

First Trust Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 2,355,502 shares — an estimated $24.2M sold.

First Trust Capital Management first reported a position in DALS in Q1 2023 and held it in 2 quarters. The position peaked at $24.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

First Trust Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
First Trust Capital Management sold 2,355,502 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $24.2M.
First Trust Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 2 quarters.
First Trust Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $24.2M in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on First Trust Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.